SHELBY PITTS: Open Payments
NPI 1679079784 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 37 payments from 12 companies in 2025. Trend: 2023 $300 · 2024 $676 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $200 |
| ABBVIE INC. | 17 | $160 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Amgen Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Organon LLC | 1 | $17 |
Products named: BREZTRI, VRAYLAR, Sunosi, QULIPTA, EVENITY, UBRELVY, The Cologuard Plus Collection Kit, ImmunoCAP.
Industry payments across UT — which companies pay providers there.
